See what happens when the clinical trial site comes to the patient.
Step into Science 37’s “living room” at Booth #110 at SCRS 2026 for a firsthand look at how a direct-to-patient study visit works in practice.
Science 37 operates as a single clinical research site with nationwide reach, bringing protocol-required visits directly to participants’ homes through Research-Grade Nurses and real-time Investigator oversight. With one Form FDA 1572 and one central IRB, sponsors can expand patient access without adding a network of individual sites.
Backed by more than a decade of experience, 200+ Phase I–IV trials, and multiple successful FDA inspections, Science 37’s Direct-to-Patient Site is built to help sponsors reach more patients, reduce the burden of participation, and deliver enrollment with the quality and oversight expected of a traditional clinical research site.
